首页> 外文期刊>Gastrointestinal Endoscopy >Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system.
【24h】

Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system.

机译:内窥镜真空辅助封闭系统治疗重大的胃食管后胸腔漏。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Endoscopic treatment options for postsurgical intrathoracic leaks include injection of fibrin glue, clip application, and stent placement. Endoscopic vacuum-assisted closure (E-VAC) may be an effective treatment option. OBJECTIVE: To demonstrate that E-VAC is an effective endoscopic treatment option for closure of major intrathoracic postsurgical leaks. DESIGN AND SETTING: A prospective, single-center study at an academic medical center. PATIENTS: Eight consecutive patients with major intrathoracic postsurgical leaks. INTERVENTIONS: Endoscopic placement of transnasal draining tubes, armed with a size-adjusted sponge at their distal end, in the necrotic anastomotic cavities, followed by continuous suction. Sponge and drainage were changed twice weekly. Patients were followed-up for 193 +/- 137 days. MAIN OUTCOME MEASUREMENT: Successful leak closure. RESULTS: Successful closure of leaks was achieved in 7 of 8 patients (88%) after a mean of 23 +/- 8 days. A median of 7 endoscopic interventions was necessary. No major treatment-associated short-term or long-term (follow-up, 193 +/- 137 days) complications were noted. LIMITATIONS: Small sample size, single-center study, and lack of randomization. CONCLUSION: E-VAC is an effective endoscopic treatment modality for major postsurgical intrathoracic leaks. (This study is registered at Clinicaltrials.gov, identifier NCT00876551.).
机译:背景:手术后胸腔内漏的内窥镜治疗选择包括注射纤维蛋白胶,施夹和支架置入。内窥镜真空辅助封闭术(E-VAC)可能是一种有效的治疗选择。目的:证明E-VAC是一种有效的内窥镜治疗方法,可用于闭合主要的胸腔内术后渗漏。设计与设置:在学术医学中心进行的前瞻性单中心研究。患者:连续八例患者出现重大胸腔内术后渗漏。干预措施:鼻内引流管的内窥镜放置在坏死的吻合腔内,并在远端穿上大小可调的海绵,然后连续抽吸。每周两次更换海绵和排水。对患者进行了193 +/- 137天的随访。主要指标:成功关闭泄漏。结果:平均23 +/- 8天后,有8位患者中有7位(88%)成功地关闭了渗漏。中位数为7例内镜干预是必要的。没有发现与短期或长期(随访,193 +/- 137天)相关的重大治疗相关并发症。局限性:样本量小,单中心研究且缺乏随机性。结论:E-VAC是一种有效的内镜治疗方式,可用于治疗重大的术后胸腔内渗漏。 (该研究已在Clinicaltrials.gov上注册,标识为NCT00876551。)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号